Former Hiroshima Toyo Carp player Ryutaro Hazuki admitted to using the specified drug etomethate during his first trial at the Hiroshima District Court [1, 2].

The case highlights the legal risks associated with "zombie tobacco," a substance that has drawn increasing scrutiny from Japanese health and law enforcement officials. Because the drug is regulated under the Pharmaceutical and Medical Device Act, its use can lead to severe criminal penalties for public figures and private citizens alike.

Hazuki, 26, is accused of violating the Pharmaceutical and Medical Device Act [2]. According to court documents, the alleged use of the substance occurred in December of last year [2].

During the proceedings, the prosecution requested a sentence of one year of imprisonment [2]. The defense countered this request by asking the court for a suspended sentence [2].

Etomethate is the chemical component often found in products marketed as zombie tobacco. The name derives from the drug's potential to cause a state of semi-consciousness or lack of motor control in users. The Japanese government classifies such substances as specified drugs, meaning their distribution and use are strictly controlled to prevent public health crises.

This trial marks the first formal court appearance for Hazuki regarding these specific charges. The court will now weigh the prosecution's demand for prison time against the defense's plea for leniency [2].

“Former Hiroshima Toyo Carp player Ryutaro Hazuki admitted to using the specified drug etomethate”

The prosecution of a former professional athlete for using etomethate signals a tightening of enforcement regarding 'zombie tobacco' in Japan. By seeking a prison sentence rather than a fine, prosecutors are attempting to create a deterrent against the use of specified drugs that fall outside traditional narcotics categories but still pose significant public health risks.